Evidence map›Paper›PMID 33419373›Full record

ReviewInternational journal of molecular sciences2020

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Griselda A Cabral-Pacheco, Idalia Garza-Veloz, Claudia Castruita-De la Rosa, Jesús M Ramirez-Acuña, Braulio A Perez-Romero, Jesús F Guerrero-Rodriguez, Nadia Martinez-Avila, Margarita L Martinez-Fierro

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06503315 (Genetic Polymorphism in Matrix Metalloproteinase 9 in Chronic Obstructive Pulmonary Disease in Sohag University Hospital.), which is not on this map. Cited by 964 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
964citing papers in PubMed, 4 pooled it
48.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06503315 unknown statusnot on this mapstarted 2024, after this paper: background citation

Genetic Polymorphism in Matrix Metalloproteinase 9 in Chronic Obstructive Pulmonary Disease in Sohag University Hospital.

TypeobservationalSponsorSohag UniversityRan2024 to 2026Enrolled70ConditionsChronic Obstructive Pulmonary Disease
3 · Its place in the literature

Who cites it

964 citing papers in PubMed, 4 syntheses or guidelines pooled it, 1,634 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

904 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Griselda A Cabral-PachecoMolecular Medicine Laboratory, Unidad Académica de Medicina Humana y Ciencias de la Salud, Carretera Zacatecas-Guadalajara Km.6. Ejido la Escondida, Zacatecas 98160, Mexico.
Idalia Garza-VelozMolecular Medicine Laboratory, Unidad Académica de Medicina Humana y Ciencias de la Salud, Carretera Zacatecas-Guadalajara Km.6. Ejido la Escondida, Zacatecas 98160, Mexico.ORCID 0000-0002-6307-1696
Claudia Castruita-De la RosaMolecular Medicine Laboratory, Unidad Académica de Medicina Humana y Ciencias de la Salud, Carretera Zacatecas-Guadalajara Km.6. Ejido la Escondida, Zacatecas 98160, Mexico.
Jesús M Ramirez-AcuñaMolecular Medicine Laboratory, Unidad Académica de Medicina Humana y Ciencias de la Salud, Carretera Zacatecas-Guadalajara Km.6. Ejido la Escondida, Zacatecas 98160, Mexico.ORCID 0000-0002-9183-2034
Braulio A Perez-RomeroMolecular Medicine Laboratory, Unidad Académica de Medicina Humana y Ciencias de la Salud, Carretera Zacatecas-Guadalajara Km.6. Ejido la Escondida, Zacatecas 98160, Mexico.
Jesús F Guerrero-RodriguezMolecular Medicine Laboratory, Unidad Académica de Medicina Humana y Ciencias de la Salud, Carretera Zacatecas-Guadalajara Km.6. Ejido la Escondida, Zacatecas 98160, Mexico.
Nadia Martinez-AvilaMolecular Medicine Laboratory, Unidad Académica de Medicina Humana y Ciencias de la Salud, Carretera Zacatecas-Guadalajara Km.6. Ejido la Escondida, Zacatecas 98160, Mexico.
Margarita L Martinez-FierroMolecular Medicine Laboratory, Unidad Académica de Medicina Humana y Ciencias de la Salud, Carretera Zacatecas-Guadalajara Km.6. Ejido la Escondida, Zacatecas 98160, Mexico.ORCID 0000-0003-1478-9068
Universidad Autónoma de Zacatecas "Francisco García Salinas" · MX

Funding

Programa de Doctorado en Ciencias con Orientación en Medicina Molecular NA
6 · The paper itself

Abstract

Matrix metalloproteinases (MMPs) are a family of zinc-dependent extracellular matrix (ECM) remodeling endopeptidases that have the capacity to degrade almost every component of the ECM. The degradation of the ECM is of great importance, since it is related to embryonic development and angiogenesis. It is also involved in cell repair and the remodeling of tissues. When the expression of MMPs is altered, it can generate the abnormal degradation of the ECM. This is the initial cause of the development of chronic degenerative diseases and vascular complications generated by diabetes. In addition, this process has an association with neurodegeneration and cancer progression. Within the ECM, the tissue inhibitors of MMPs (TIMPs) inhibit the proteolytic activity of MMPs. TIMPs are important regulators of ECM turnover, tissue remodeling, and cellular behavior. Therefore, TIMPs (similar to MMPs) modulate angiogenesis, cell proliferation, and apoptosis. An interruption in the balance between MMPs and TIMPs has been implicated in the pathophysiology and progression of several diseases. This review focuses on the participation of both MMPs (e.g., MMP-2 and MMP-9) and TIMPs (e.g., TIMP-1 and TIMP-3) in physiological processes and on how their abnormal regulation is associated with human diseases. The inclusion of current strategies and mechanisms of MMP inhibition in the development of new therapies targeting MMPs was also considered.

Indexed as

Chronic DiseaseDiabetes MellitusExtracellular MatrixHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix MetalloproteinasesNeovascularization, PhysiologicTissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of Metalloproteinase-3Tissue Inhibitor of MetalloproteinasesMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix MetalloproteinasesTissue Inhibitor of Metalloproteinase-1Tissue Inhibitor of Metalloproteinase-3Tissue Inhibitor of Metalloproteinaseshuman diseasesmatrix metalloproteinasesmetalloproteinase inhibitors

Identifiers

PMID33419373
PMCPMC7767220
OpenAlexW3117437033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.